STA9090 as a Potential Therapeutic Agent for Liver Fibrosis by Modulating the HSP90/TβRII/Proteasome Interplay: Novel Insights from In Vitro and In Vivo Investigations

Liver fibrosis is a progressive condition characterized by the build-up of fibrous tissue resulting from long-term liver injury. Although there have been advancements in research and treatment, there is still a need for effective antifibrotic medication. HSP90 plays a crucial role in the development...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohammed, Osama A., Abdel-Reheim, Mustafa Ahmed, Alamri, Mohannad Mohammad S., Alfaifi, Jaber, Adam, Masoud I. E., Saleh, Lobna A., Farrag, Alshaimaa A., Yahia, Amar Ibrahim Omer, Abdel-Ghany, Sameh, AlQahtani, AbdulElah Al Jarallah, Bahashwan, Emad, Eltahir, Hanan B., Mohammed, Nahid A., El-wakeel, Hend S., Hazem, Sara H., Saber, Sameh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459039/
https://www.ncbi.nlm.nih.gov/pubmed/37630994
http://dx.doi.org/10.3390/ph16081080

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459039/
https://www.ncbi.nlm.nih.gov/pubmed/37630994
http://dx.doi.org/10.3390/ph16081080

Ejemplares similares